Category survey

Varenicline, a nicotinic receptor agonist for the treatment of Excessive Daytime Sleepiness in Parkinson’s Disease: a placebo-controlled cross-over pilot study. Investments < €500k Netherlands 2016    

DNA-isolaties LEAP-study Investments < €500k Netherlands 2016    

FIT Investments < €500k Netherlands 2016    

Roodkapje Investments < €500k Netherlands 2016    

Mechanismen van Amyloid ß eiwit-klaring in Cerebrale Amyloid Angiopathie. Mechanisms of Amyloid β protein clearance in cerebral amyloid angiopathy Investments < €500k Netherlands 2016    

Genetische risicofactoren en proteostasis bij de ziekte van Alzheimer. Genetic risk factors and proteostasis in Alzheimer’s disease Investments < €500k Netherlands 2016    

De rol van het ceramide transporter proteine (CERT) bij de ziekte van Alzheimer. The role of the ceramide transporter protein (CERT) in Alzheimer’s disease Investments < €500k Netherlands 2016    

Variatie in mRNA bij de ziekten van Alzheimer en Parkinson. Variation in mRNA in Alzheimer’s and Parkinson’s Diseases Investments < €500k Netherlands 2016    

In vivo optische detectie van Amyloid Beta plaques in de menselijke retina. In vivo optical detection of Amyloid Beta plaques in the human retina Investments < €500k Netherlands 2016    

Drainage van Amyloid ß via de perivasculaire ruimte. Drainage of Amyloid ß via the perivascular space Investments < €500k Netherlands 2016    

De rol van SPPL2b bij pathogenese van de ziekte van Alzheimer. The role of SPPL2b in Alzheimer’s disease pathogenesis Investments < €500k Netherlands 2016    

De ziekte van Alzheimer en de epigenetische programmering van neurale stamcellen door stress. Alzheimer’s disease and epigenetic programming of neural stem cells by stress Investments < €500k Netherlands 2016    

De ERAD-C eiwitafbraak-route bij de ziekte van Alzheimer. The ERAD-C protein degradation pathway in Alzheimer’s disease Investments < €500k Netherlands 2016    

Chaperonnes en de aggregatie van Tau. Chaperonnes and the aggregation of Tau Investments < €500k Netherlands 2016    

Impaired Axonal transport in Alzheimer’s disease Investments < €500k Netherlands 2016    

Does sleep deprivation increase Alzheimer’s disease risk by disruption of amyloid-bBeta clearance Investments < €500k Netherlands 2016    

How noradrenaline modulates memory and the brain in Alzheimer’s disease Investments < €500k Netherlands 2016    

Restoring memory by activating liver x receptors* Investments < €500k Netherlands 2016    

Identification of novel aβ-associated proteins Investments < €500k Netherlands 2016    

Blood-brain barriar clearance of aβ peptides in Alzheimer’s disease models Investments < €500k Netherlands 2016    

Lipocalin-2 vergroot de gevoeligheid van zenuwcellen voor Aβ. Lipocalin-2 increases the sensitivity of nerve cells to Aβ Investments < €500k Netherlands 2016    

DNMT3a: een epigenetische regelaar van cognitieve achteruitgang? DNMT3a: An epigenetic controller of cognitive decline? Investments < €500k Netherlands 2016    

ROSETTA implementatie Investments < €500k Netherlands 2016    

Lessen van patiënten – dementie. Lessons from patients – dementia Investments < €500k Netherlands 2016    

PhenotYpe Research for ALS ModIfyer Discovery (PYRAMID) Investments < €500k Netherlands 2016    

Beter Thuis met Dementie: doorontwikkeling en effectonderzoek van een innovatief programma voor mantelzorgers en hun naaste. Better Home with Dementia: development and impact research of an innovative program for caregivers and their neighbors. Investments < €500k Netherlands 2016    

Project Inlife. Evaluatie van de bruikbaarheid en effectiviteit van een virtueel sociaal platform voor mantelzorgers en mensen met dementie. Project Inlife. Evaluation of the usefulness and effectiveness of a virtual social platform for caregivers and people with dementia Investments <…

Groene initiatieven in de stad voor thuiswonende ouderen met dementie en hun mantelzorgers. Green initiatives in the city for home-living elderly people with dementia and their caregivers Investments < €500k Netherlands 2016    

De mond niet vergeten! Implementatieproject voor goede mondzorg voor thuiswonende ouderen met dementie. Do not forget the mouth! Implementation project for good oral care for home-grown elderly people with dementia Investments < €500k Netherlands 2016    

Gebruik van Oud-Mantelzorgervaring voor betere dementiezorg thuis. Use of Early Care Care for better dementia care at home Investments < €500k Netherlands 2016    

Onderzoek naar de (kosten)effectiviteit van DementTalent: een innovatieve vorm van begeleiding van mensen met dementie en hun mantelzorgers. Research on the (cost) effectiveness of DementTalent: an innovative form of guidance for people with dementia and their caregivers Investments < €500k…

SPANkracht: een Sociale, Plezierige, Actieve Nuttige daginvulling op eigen kracht voor jonge mensen met dementie. SPANNING Power: A Social, Enjoyable, Active Useful Day-to-Day Infusion for Young People With Dementia Investments < €500k Netherlands 2016    

Effectivity of a mixed-reality dementia simulator: does it enhance empathy and reduce burden in informal caregivers Investments < €500k Netherlands 2016    

Bevorderen van plezierige fysieke activiteiten en kwaliteit van leven bij dementie: onderzoek naar de (kosten)effectiviteit van exergaming. Promoting enjoyable physical activities and quality of life in dementia: research into the (cost) effectiveness of exergaming Investments < €500k Netherlands 2016  …

Online levensalbum: Een onderzoek naar het effect voor mensen met beginnende dementie en hun mantelzorgers. Online Life Album: An investigation into the effect for people with beginner dementia and their caregivers Investments < €500k Netherlands 2016    

Passief bewegen voor een actiever brein bij dementie. Passively move for a more active brain in dementia Investments < €500k Netherlands 2016    

Vrijwillige inzet in het mantelzorgsysteem rond thuiswonende mensen met dementie: diversiteit en randvoorwaarden. Voluntary involvement in the wrist care system around home-living people with dementia: diversity and preconditions Investments < €500k Netherlands 2016    

Towards the understanding of pathological protein processing and toxicity in Machado-Joseph disease. Investments < €500k Netherlands 2016    

Advancing the European Multidisciplinary Initiative on Neuroacanthocytosis – EMINA-2: Dissecting the molecular pathophysiology of Chorea-Acanthocytosis Investments < €500k Netherlands 2016    

Adult neural stem cells from post-mortem human brain: Towards an in vitro model for stimulating neurogenesis in neurodegenerative diseases. Investments < €500k Netherlands 2016    

Make-believe Matters. The Moral Role Things Play in Dementia Care. Investments < €500k Netherlands 2016    

Early diagnosis of Alzheimer’s disease: conceptual considerations and ethical guidance Investments < €500k Netherlands 2016    

Analysis of genetic modulators for mitochondrial dysfunction in alpha-synuclein models for Parkinson`s disease Investments < €500k Luxembourg 2016    

Investigating the role of DJ-1/LRRK2 and RhoT1 in microglial polarization Investments < €500k Luxembourg 2016    

Role of neuroinflammation in prion-like α-synuclein spreading in the mouse brain Investments < €500k Luxembourg 2016    

Characterization of a Parkinson’s disease gene DJ-1 in regulatory T cells Investments < €500k Luxembourg 2016    

Mitochondrial endophenotypes of PD Investments < €500k Luxembourg 2016    

The Parkinson’s disease associated Pink1-Parkin-RhoT1 pathway in pathology and development Investments < €500k Luxembourg 2016    

Computational prediction of biochemical compensatory mechanisms in subjects at risk of developing Parkinson’s disease. Investments < €500k Luxembourg 2016    

Cellular Mosaicism as a cause for Parkinson’s disease. Investments < €500k Luxembourg 2016